# Adalimumab-aacf

NDC: 65219-620
Generic name: adalimumab
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: SUBCUTANEOUS
Marketing started: 20240630

FDA application: BLA761255

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65219-620"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65219-620
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2488b0bc-7b8f-4cc8-91ea-48e7ea5e8915